Niek P. van Til

1.2k citations

44 papers · 879 indexed · h-index 18

Genetics top 5%
- Virus-based gene therapy research 23
- Neurogenetic and Muscular Disorders Research 3
Molecular Biology
- RNA Interference and Gene Delivery 11
- CRISPR and Genetic Engineering 11
- Biochemical and Molecular Research 6
Genetics
- Virus-based gene therapy research 23
- Neurogenetic and Muscular Disorders Research 3
Oncology
- CAR-T cell therapy research 13
Rheumatology top 10%
Physiology
- Lysosomal Storage Disorders Research 8
Immunology
- Immunotherapy and Immune Responses 3

Co-authors: Jurgen Seppen Gerard Wagemaker Ronald P.J. Oude Elferink Trudi P. Visser Johan K. Hiralall Norbert Looije Stefan Nierkens Wouter H. Lamers
Cited by: Genetics Molecular Biology
Journals: Blood (2 papers)PLoS ONE (1 paper)International Journal of Molecular Sciences (1 paper)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Niek P. van Til

42 papers receiving 864 citations

Peers

Countries citing papers authored by Niek P. van Til

Since Specialization

Citations

This map shows the geographic impact of Niek P. van Til's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niek P. van Til with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niek P. van Til more than expected).

Fields of papers citing papers by Niek P. van Til

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niek P. van Til. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niek P. van Til. The network helps show where Niek P. van Til may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Niek P. van Til, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Niek P. van Til Line = papers co-authored together Niek P. van Til links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML Journal for ImmunoTherapy of Cancer ·Vania Lo Presti,Angelo D. Meringa,Ester Dünnebach,Alice van Velzen,A Moreira,Ronald W. Stam,Rishi S. Kotecha,Anja Krippner‐Heidenreich,Olaf Heidenreich,Maud Plantinga,Annelisa M. Cornel,Zsolt Sebestyén,Jürgen Kuball,Niek P. van Til,Stefan Nierkens	2024	3
2	Human post-mortem organotypic brain slice cultures: a tool to study pathomechanisms and test therapies Acta Neuropathologica Communications ·Bonnie C. Plug,Ilma M. Revers,Marjolein Breur,Gema Muñoz González,Jaap A. Timmerman,Niels Meijns,Daniek Hamberg,Jikke Wagendorp,Erik Nutma,Nicole I. Wolf,Antonio Luchicchi,Huibert D. Mansvelder,Niek P. van Til,Marjo S. van der Knaap,Marianna Bugiani	2024	6
3	Gene Therapy for Inherited Liver Disease: To Add or to Edit International Journal of Molecular Sciences ·Yue Chen,Niek P. van Til,Piter J. Bosma	2024	1
4	Gene and Cellular Therapies for Leukodystrophies Pharmaceutics ·Fatima Aerts‐Kaya,Niek P. van Til	2023	3
5	Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA Annals of Clinical and Translational Neurology ·Marianna Bugiani,Truus E. M. Abbink,Arthur W. D. Edridge,Lia van der Hoek,Anne E.J. Hillen,Niek P. van Til,Gino V. Hu‐A‐Ng,Marjolein Breur,Karen Aiach,Philippe Drevot,Michaël Hocquemiller,Ralph Laufer,Frits A. Wijburg,Marjo S. van der Knaap	2023	6
6	Lentiviral gene therapy with IGF2-tagged GAA normalizes the skeletal muscle proteome in murine Pompe disease Journal of Proteomics ·Qiushi Liang,Eva C. Vlaar,Joon M. Pijnenburg,Erikjan Rijkers,Jeroen Demmers,Arnold G. Vulto,Ans T. van der Ploeg,Niek P. van Til,W.W.M. Pim Pijnappel	2023	5
7	Lentiviral gene therapy prevents anti-human acid α-glucosidase antibody formation in murine Pompe disease Molecular Therapy — Methods & Clinical Development ·Qiushi Liang,Eva C. Vlaar,Fabio Catalano,Joon M. Pijnenburg,Merel Stok,Yvette van Helsdingen,Arnold G. Vulto,Wendy W. J. Unger,Ans T. van der Ploeg,W.W.M. Pim Pijnappel,Niek P. van Til	2022	12
8	High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosing Molecular Therapy ·Robert N. Plasschaert,Mark P. DeAndrade,Fritz Hull,Quoc Nguyen,Tara Peterson,Aimin Yan,Mariana Loperfido,Cristina Baricordi,Luigi Barbarossa,John K. Yoon,Yildirim Dogan,Zeenath Unnisa,Jeffrey W. Schindler,Niek P. van Til,Luca Biasco,Chris Mason	2022	9
9	IGF2-tagging of GAA promotes full correction of murine Pompe disease at a clinically relevant dosage of lentiviral gene therapy Molecular Therapy — Methods & Clinical Development ·Qiushi Liang,Fabio Catalano,Eva C. Vlaar,Joon M. Pijnenburg,Merel Stok,Yvette van Helsdingen,Arnold G. Vulto,Ans T. van der Ploeg,Niek P. van Til,W.W.M. Pim Pijnappel	2022	19
10	Efficient lentiviral transduction method to gene modify cord blood CD8+ T cells for cancer therapy applications Molecular Therapy — Methods & Clinical Development ·Vania Lo Presti,Annelisa M. Cornel,Maud Plantinga,Ester Dünnebach,Jürgen Kuball,Jaap Jan Boelens,Stefan Nierkens,Niek P. van Til	2021	9
11	Gene Augmentation and Editing to Improve TCR Engineered T Cell Therapy against Solid Tumors Vaccines ·Vania Lo Presti,Frank Buitenwerf,Niek P. van Til,Stefan Nierkens	2020	12
12	A “No‐Touch” Antibody‐Staining Method of Adherent Cells for High‐Throughput Flow Cytometry in 384‐Well Microplate Format for Cell‐Based Drug Library Screening Cytometry Part A ·Annelisa M. Cornel,Celina L. Szanto,Niek P. van Til,Jeroen F. van Velzen,Jaap Jan Boelens,Stefan Nierkens	2019	3
13	Transplantation, gene therapy and intestinal pathology in MNGIE patients and mice BMC Gastroenterology ·Rana Yadak,Max V. Boot,Niek P. van Til,Dominique Cazals‐Hatem,Armin Finkenstedt,Elly Bogaerts,I.F.M. de Coo,Marianna Bugiani	2018	15
14	Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies Frontiers in Immunology ·Annelisa M. Cornel,Niek P. van Til,Jaap Jan Boelens,Stefan Nierkens	2018	14
15	Preclinical Efficacy and Safety Evaluation of Hematopoietic Stem Cell Gene Therapy in a Mouse Model of MNGIE Molecular Therapy — Methods & Clinical Development ·Rana Yadak,Raquel Cabrera-Pérez,Javier Torres‐Torronteras,Marianna Bugiani,Joost Haeck,Marshall W. Huston,Elly Bogaerts,Steffi Goffart,Edwin H. Jacobs,Merel Stok,Lorena Leonardelli,Luca Biasco,Robert M. Verdijk,Monique R. Bernsen,George de Ruijter,Ramón Martí,Gerard Wagemaker,Niek P. van Til,I.F.M. de Coo	2018	16
16	Enhancement of mouse hematopoietic stem/progenitor cell function via transient gene delivery using integration-deficient lentiviral vectors Experimental Hematology ·Maria E. Alonso-Ferrero,Niek P. van Til,Kerol Bartolović,M.F. Mata,Gerard Wagemaker,Dale Moulding,David A. Williams,Christine Kinnon,Simon N. Waddington,Michael D. Milsom,Steven J. Howe	2017	4
17	Recombination-activating gene 1 (Rag1)–deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome Journal of Allergy and Clinical Immunology ·Niek P. van Til,Roya Sarwari,Trudi P. Visser,Julia Hauer,Chantal Lagresle‐Peyrou,Guus van der Velden,Vidyasagar Malshetty,Patricia Cortés,Arnaud Jollet,Olivier Danos,Barbara Cassani,Fang Zhang,Adrian J. Thrasher,Elena Fontana,Pietro Luigi Poliani,Marina Cavazzana,Monique M.A. Verstegen,Anna Villa,Gerard Wagemaker	2013	46
18	Correction of Murine SCID-X1 by Lentiviral Gene Therapy Using a Codon-optimized IL2RG Gene and Minimal Pretransplant Conditioning Molecular Therapy ·Marshall W. Huston,Niek P. van Til,Trudi P. Visser,Shazia Arshad,Martijn H. Brugman,Claudia Cattoglio,Ali Nowrouzi,Yuedan Li,Axel Schambach,Manfred Schmidt,Christopher Baum,Christof von Kalle,Fulvio Mavilio,Fang Zhang,Michael P. Blundell,Adrian J. Thrasher,Monique M.A. Verstegen,Gerard Wagemaker	2011	26
19	Physiological tonicity improves human chondrogenic marker expression through nuclear factor of activated T-cells 5 in vitro Arthritis Research & Therapy ·Anna E. van der Windt,Esther Haak,R. Das,Nicole Kops,Tim J. M. Welting,Marjolein MJ Caron,Niek P. van Til,Jan A.N. Verhaar,Harrie Weinans,Holger Jahr	2010	47
20	Immune response to lentiviral bilirubin UDP-glucuronosyltransferase gene transfer in fetal and neonatal rats Gene Therapy ·Jurgen Seppen,Niek P. van Til,Roos van der Rijt,Johan K. Hiralall,Cindy Kunne,Ronald P.J. Oude Elferink	2005	34

About Niek P. van Til

Niek P. van Til is a scholar working on Genetics, Oncology and Developmental Neuroscience, having authored 44 papers that have together received 879 indexed citations. Recurring topics across this work include Virus-based gene therapy research (23 papers), CAR-T cell therapy research (13 papers), RNA Interference and Gene Delivery (11 papers), CRISPR and Genetic Engineering (11 papers), Lysosomal Storage Disorders Research (8 papers), Biochemical and Molecular Research (6 papers), Neurogenetic and Muscular Disorders Research (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Genetics (352 citations), Molecular Biology (476 citations) and Genetics (72 citations). Niek P. van Til has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Jurgen Seppen, Gerard Wagemaker, Ronald P.J. Oude Elferink, Trudi P. Visser, Johan K. Hiralall, Norbert Looije, Stefan Nierkens, Wouter H. Lamers, Rana Yadak and Merel Stok. Their work appears in journals such as Blood, PLoS ONE and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact